ZMUni Compliance Centre

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics in China and globally in August 2026, with an emphasis on updates in cosmetic ingredients and cosmetic management, among other areas.     China Cosmetic Regulatory Updates   New Cosmetics Ingredients (NCI) In August 2026, 5 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include:   The technical requirements for the 5 NCIs mentioned above have not

  In August, a total of five new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA), significantly fewer than in previous months. The technical requirements for all related NCIs have not yet been publicly disclosed.     Camellia Petelotii Callus   Camellia petelotii is a species of the genus Camellia in the family Theaceae, mainly distributed in southern Guangxi, China, with limited distribution in Yunnan, Guangdong, and other regions.   Since 2021, related Camellia chrysantha ingredients have been notified nine times. This marks the first notification of Camellia petelotii callus.   The notifier, Hangzhou Shicang Xinya Biotechnology

    On August 27, 2026, China's National Center for ADR Monitoring released the Guidelines for Preparing Self-Inspection Reports on Adverse Reactions to Cosmetics by Registrants and Notifiers, providing guidance on the preparation of adverse reaction self-inspection reports by cosmetic registrants, notifiers, and domestic responsible persons in China. Key points of the Guidelines include:     Scope & Applicable Entities The Guidelines apply to cosmetic registrants, notifiers, and domestic responsible persons in China.      Strict Reporting Deadlines Serious adverse reactions: A self-inspection report must be submitted within 20 days from the date the adverse reaction is identified/known. Adverse reactions that

Ampoules, vials, and syringe-type containers—packaging formats commonly associated with pharmaceutical and injectable products—are increasingly used for cosmetic products such as serums and concentrated skincare treatments. However, these formats may be subject to regulatory considerations beyond those applicable to conventional cosmetics, as their appearance can create a risk of consumer misunderstanding or misuse.   Thailand is one market where this distinction is particularly important. The Thai Food and Drug Administration (Thai FDA) has established specific requirements for cosmetic products packaged in ampoules, vials, or syringe-type containers, covering their intended use, packaging, labeling, and supporting documentation. In this article, ZMUni Compliance Centre

    On August 24, 2026, China's National Medical Products Administration (NMPA) issued the cosmetics industry standard YY/T 10006—2026, General Technical Requirements for Cosmetic Product Standards. The standard will take effect on January 1, 2027.   The standard aims to establish a unified framework for developing cosmetic product standards, including rules for product classification and baseline technical requirements.   Given the diversity of cosmetic products and the overlap of factors such as product form, manufacturing process, intended efficacy, application site, and method of use, product categories must be clearly defined when developing product standards.   The standard requires cosmetic product

   On August 19, 2026, China's National Institutes for Drug Control (NIDC) made the fifth dynamic adjustment to the Inventory of Existing Cosmetic Ingredients in China (IECIC).   Four new  cosmetic ingredients — CETYL DIGLYCERYL TRIS(TRIMETHYLSILOXY)SILYLETHYL DIMETHICONE, NICOTINAMIDE MONONUCLEOTIDE, BAKUCHIOL and AZELAMIDOPROPYL DIMETHYL AMINE — have completed their three-year safety monitoring period. Following an assessment confirming compliance with the Cosmetic Supervision and Administration Regulation (CSAR) and other applicable requirements, they have been added to List II of the IECIC.   For companies, inclusion in List II means that these ingredients have transitioned from "new cosmetic ingredients" to "existing cosmetic ingredients",

On July 2, 2026, the State Administration for Market Regulation (SAMR) and the Standardization Administration of China (SAC) approved 508 recommended national standards and one amendment. Among them is GB/T 29602-2026 Quality Requirements for Solid Beverages (hereinafter referred to as GB/T 29602-2026).   Developed under the leadership of the China Beverage Industry Association, GB/T 29602-2026 will take effect on August 1, 2027, replacing GB/T 29602-2013.       Overview of the Key Changes   China's solid beverage market has expanded rapidly in recent years, alongside growing concerns over unclear product definitions, blurred category boundaries, and misleading labeling and claims. GB/T

This article provides a comprehensive overview of key regulatory developments in the food sector in July 2026, both in China and internationally. It focuses on updates related to new food ingredients, food additives, health foods, and feed, aiming to offer timely and in-depth regulatory alerts for enterprises engaged in food import and export.   China Food Regulatory Updates   🔘 China Three New Food Updates (July 2026)   In July 2026, the National Health Commission (NHC) released two notices, seeking comments on 4 new food ingredients and four new food additive varieties. For further reading, read our previous articles below: